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The Food and Drug Administration’s (FDA) 
Mini-Sentinel is a pilot program that aims to 
conduct active surveillance 
to detect and refine safety signals that 
emerge for 
marketed medical products. 
The purpose of  this Mini-Sentinel AMI 
Validation project was to:
(a) develop and design an 
abstraction and adjudication process to use 
when full text medical record review is 
required to confirm a coded diagnosis; 
and
(b) to test this approach by validating a code 
algorithm for acute myocardial infarction 
(AMI). 
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DP1 26 6 32 81.3 64.7, 91.1
DP2 29 9 38 76.3 60.8, 87.0
DP3 33 2 35 94.3 81.4, 98.4
DP4 35 3 38 92.1 79.2, 97.3
OVERALL 123 20 143 86.0 79.4, 90.8
A PPV of  86% may be considered adequate 
for some surveillance activities relevant to 
medication and device safety, but not for 
others.  
Further research may be merited examining 
between-age group and between-gender 
differences in the positive predictive value of  
this AMI identification algorithm.
The Mini-Sentinel AMI Validation project was a collaboration 
between the FDA, the Mini-Sentinel Operations Center, and selected 
Academic and Data Partners.  Four Mini-Sentinel Data Partners 
participated in this project: (1) HealthCore, Inc.; (2) Humana; (3) 
three member health plans within the Kaiser Permanente Center for 
Effectiveness and Safety Research; and (4) two member health plans 
within the HMO Research Network.
Availability of Cardiac-Specific 
Chart Components
(1) AMI Case Identification
Goal: Establish ICD-9-CM-based algorithm to 
identify patients hospitalized for AMI within the 
Mini-Sentinel Distributed Database
Approach: Reviewed previous validation studies. 
Considered using a broad algorithm (incorporating 
Acute Coronary Syndrome codes, or codes to capture 
death after ER discharge).
Algorithm:  Include ICD-9 hospital discharge codes 
(a principal or primary discharge code only) of  410.x0 
and 410.x1.
(2) AMI Case Retrieval
Goal: Establish and carry out procedure for chart 
retrieval and extraction, ensuring patient privacy, 
collecting and transferring the minimal amount of  
de-identified information needed to validate potential 
cases of  AMI.
Approach: 
(1) Identify required chart components (examples: 
EKG’s, cardiac biomarkers, dictated doctor notes).
(2) Determine whether chart abstraction would take 
place centrally or in a locally distributed 
fashion; (Centralized approach was chosen)
(3) Establish protocols for ensuring the privacy and 
security of  data and for explaining the status of  
this effort as a public health surveillance 
activity not under the oversight of  IRBs. 
(3) Abstraction
Goal: Design abstraction form and train 2 nurse abstractors 
to gather key data for AMI validation.
Approach: 36-item abstraction form included 
demographic information, brief  medical history, biomarker 
data, EKG copies, cardiac test results and disposition at 
discharge. 
(4) Adjudication
Goal: Design protocol-driven Adjudication process 
Approach: Protocol developed based on American 
Heart Association Universal Definition of  MI.  Two 
UMass Cardiologists independently reviewed each case 
and classified as (1) Definite MI; (2) Probable MI; (3) 
No MI; or (4) Unable to Determine.  Cardiologists met 
to reach consensus in cases where they differed. 
(5) Calculation of  PPV
(Positive Predictive Value)
Goal: Calculate PPV of  algorithm (ratio of  confirmed 
AMI cases to all identified cases)
Approach: 
PPV = Definite + Probable AMI 
All retrieved cases
Note: DP1 through 4 indicates Data Partners 1-4.
Subgroup PPV’s:
age <75 (74 charts) = 94.6% (95% CI 86.9 to 97.9)
age 75+ (53 charts) = 79.2% (66.5 to 88.0)
males (76 charts) = 93.4% (88.5 to 97.2)
females (67 charts) 77.6% (63.3 to 85.9)
Lower PPV for females: driven by the women in 75+ age 
group
Women <75 (29 charts) 93.1% (78.0 to 98.1); 
Women 75+ (27 charts) 70.4% (51.5 to 84.1)
